Researchers discover how natural drug fights inflammation
2010-12-10
(Press-News.org) Researchers at the Virginia Bioinformatics Institute at Virginia Tech have discovered how abscisic acid, a natural plant hormone with known beneficial properties for the treatment of disease, helps fight inflammation. The results (http://www.ncbi.nlm.nih.gov/pubmed/210882970), which are published in the November 2010 Journal of Biological Chemistry, reveal important new drug targets for the development of treatments for inflammatory and immune-mediated diseases.
The scientists had reported some of the key molecular events in the immune system of mice that contribute to inflammation-related disease, including the involvement of a specific molecule found on the surface of immune cells involved in the body's fight against infection (http://www.ncbi.nlm.nih.gov/pubmed/21068720). They have now gone one step further and revealed the mechanism by which the natural drug abscisic acid interacts with this protein, known as peroxisome proliferator-activated receptor-gamma, to block inflammation and the subsequent onset of disease.
"In previous work, our research group demonstrated that abscisic acid has beneficial effects on several conditions and diseases including obesity-related inflammation, diabetes, atherosclerosis, and inflammatory bowel disease," said Josep Bassaganya-Riera, associate professor of immunology at the Virginia Bioinformatics Institute, leader of the Nutritional Immunology and Molecular Medicine Group in the institute's CyberInfrastructure Division, and principal investigator of the study. "One idea for how abscisic acid reduces inflammation in these instances is that it binds to a special region of peroxisome proliferator-activated receptor-gamma, a binding site known as the ligand-binding domain where the drug would be expected to latch on to and exert its effect. Our results show that this is not the case and, for the first time, we have demonstrated that abscisic acid works independently of this ligand-binding domain of the receptor."
"This information is significant because it suggests the existence of new therapeutic targets or alternative modes of action that account for the effects of abscisic acid in the immune system," added Bassaganya-Riera. "Drugs that bind to the ligand-binding domain of peroxisome proliferator-activated receptor-gamma such as Avandia are associated with severe cardiovascular side effects. In contrast, the newly discovered alternative mechanism of peroxisome proliferator-activated receptor-gamma activation by abscisic acid does not appear to be linked to any known adverse side effects, thereby representing a promising new therapeutic avenue."
"The outcomes of this research illustrate the synergism that can result from combining computational and experimental approaches to characterize therapeutic targets", said David Bevan, associate professor of biochemistry at Virginia Tech. "By using molecular modeling approaches we were able to identify a potential binding site for abscisic acid on the lanthionine synthetase C-like 2 protein, a protein required for the beneficial health effects of abscisic acid. We were also able, again using docking studies, to reveal reasons for the lack of direct association of abscisic acid with peroxisome proliferator-activated receptor-gamma, which was experimentally validated by ligand-binding assays."
"Lanthionine synthetase C-like 2 represents the first step in a pathway leading to activation of peroxisome proliferator-activated receptor-gamma in immune cells by abscisic acid," said Raquel Hontecillas, assistant professor of immunology at the Virginia Bioinformatics Institute and one of the lead investigators of the study. "We have also shown that abscisic acid affects the expression of several genes involved in inflammation, metabolism and cell signaling, which provides further clues for possible intervention points in the treatment of inflammatory and immune-mediated diseases."
The researchers hope to more closely pinpoint some of the new drug targets in the molecular network of the immune response as they continue to dissect the way that the naturally occurring drug abscisic acid reduces damage due to inflammation. In addition, the novel understanding on how abscisic acid works will be used to develop new classes of drugs that target the same alternative pathway of peroxisome proliferator-activated receptor-gamma activation, a potentially safer approach than the use of drugs that target direct binding to the receptor.
INFORMATION:
The research was funded by award number 5R01AT004308 from the National Center for Complementary and Alternative Medicine at the National Institutes of Health, European
Commission grant number 224836, the Ramon y Cajal Program, National Institute of Allergy and Infectious Diseases Contract No. HHSN272200900040C, National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C, and funds from the Nutritional Immunology and Molecular Medicine Laboratory.
About the Nutritional Immunology and Molecular Medicine Group
The Nutritional Immunology and Molecular Medicine Group conducts translational research aimed at developing novel therapeutic and prophylactic approaches for modulating immune and inflammatory responses. The group combines computational modeling, bioinformatics approaches, pre-clinical experimentation and human clinical studies to better understand the mechanisms of immune regulation at mucosal surfaces and ultimately accelerate the development of novel treatments for infectious and immune-mediated diseases. Learn more at: www.vbi.vt.edu/nimm
Learn more about Josep Bassaganya-Riera at https://www.vbi.vt.edu/vbi_faculty/vbi_persons/dev_vbi_faculty?personId=177
Related links
Immune system changes linked to inflammatory bowel disease revealed
http://www.eurekalert.org/pub_releases/2010-12/vt-isc120910.php
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-12-10
ALBUQUERQUE, N.M. — A benchtop version of the world's smallest battery — its anode a single nanowire one seven-thousandth the thickness of a human hair —has been created by a team led by Sandia National Laboratories researcher Jianyu Huang.
To better study the anode's characteristics, the tiny rechargeable, lithium-based battery was formed inside a transmission electron microscope (TEM) at the Center for Integrated Nanotechnologies (CINT), a Department of Energy research facility jointly operated by Sandia and Los Alamos national laboratories.
Says Huang of the work, ...
2010-12-10
DURHAM, N.C. – Using lasers to contain some ultra-chilled atoms, a team of scientists has measured the viscosity or stickiness of a gas often considered to be the sixth state of matter. The measurements verify that this gas can be used as a "scale model" of exotic matter, such as super-high temperature superconductors, the nuclear matter of neutron stars, and even the state of matter created microseconds after the Big Bang.
The results may also allow experimental tests of string theory in the future.
Duke physicist John Thomas made the viscosity measurements using an ...
2010-12-10
Despite a 30-year warming trend, the last three years in the Bering Sea have been the coldest on record. A University of Alaska Fairbanks scientist says that the cold temperatures have helped produce larger zooplankton in the Bering Sea, which may affect the way Walleye pollock feed.
Alexei Pinchuk, research professional at the UAF Seward Marine Center, has spent the last three years gathering zooplankton samples in the Bering Sea. He and his colleagues have been looking at how changes in temperature in the Bering Sea affect resident zooplankton and, in turn, how those ...
2010-12-10
New research suggests that private industry and academic science pursue different goals with different consequences, but that the two can still be complementary.
Over the past three decades, private funding and collaboration in university-based research has risen steadily. That has led to concerns about the independence and integrity of public science. However, University of Chicago sociologist James Evans finds that industry can advance academic science by shaking up its conservative nature and encouraging novel discovery.
Evans's research, released today in the American ...
2010-12-10
OAK RIDGE, Tenn., Dec. 9, 2010 -- A quicker and cheaper technique to scan molecular databases developed at the Department of Energy's Oak Ridge National Laboratory could put scientists on the fast track to developing new drug treatments.
A team led by Jerome Baudry of the University of Tennessee-ORNL Center for Molecular Biophysics adapted a widely used existing software to allow supercomputers such as ORNL's Jaguar to sift through immense molecular databases and pinpoint chemical compounds as potential drug candidates.
The research was published in the Journal of ...
2010-12-10
Used in the proper amounts, it can make teeth stronger and aid in the treatment of osteoporosis. When excessive amounts are consumed, however, it can be a killer — a carcinogen that causes bone, lung and bladder cancers. The "it" is fluoride, a common additive in most American communities' drinking water and an ingredient in the vast majority of commercially produced adult toothpastes.
Determining the level of fluoride, be it in water, consumer products or the human body, is an important and attractive challenge for scientists. To address that, a Florida State University ...
2010-12-10
A collaborative, government-led effort to guide and standardize diagnosis, treatment and management of food allergies has resulted in the release of an official set of recommendations for physicians.
The guidelines are being published online this week by the Journal of Allergy and Clinical Immunology (JACI), and available online at www.niaid.nih.gov/topics/foodallergy/clinical/Pages/default.aspx. They were developed by the National Institutes of Health and leading researchers and clinicians, professional and patient advocacy organizations, and the American Academy of ...
2010-12-10
Shootings like the one in which a gunman shot a doctor and killed a patient at The Johns Hopkins Hospital in September are "exceedingly rare," but the rate of other assaults on workers in U.S. health care settings is four times higher than other workplaces, conclude two Johns Hopkins emergency physicians after reviewing workplace violence in health settings.
The rate of assault in all private-sector industries in the United States is two per 10,000, compared to eight per 10,000 at health care workplaces, note Gabor D. Kelen, M.D., and Christina L. Catlett, M.D., in a ...
2010-12-10
Using buprenorphine instead of methadone — the current standard of care — to treat opioid-dependent pregnant women may result in healthier babies, suggests new findings from an international team led by Johns Hopkins researchers and published in the Dec. 9 issue of the New England Journal of Medicine.
Babies born to mothers taking buprenorphine instead of methadone to counter heroin and/or prescription opioid addiction were likely to need less morphine to deal with drug withdrawal symptoms, spent half as much time in the hospital after delivery and recovered from neonatal ...
2010-12-10
Johns Hopkins scientists have identified a previously unrecognized step in the activation of infection-fighting white blood cells, the main immunity troops in the body's war on bacteria, viruses and foreign proteins.
"It's as if we knew many of the generals, colonels and majors and now we have discovered a new officer that helps the troops carry out the right battle plan," says Joel Pomerantz, Ph.D., an assistant professor of Biological Chemistry in the Institute for Basic Biomedical Sciences and member of the Institute for Cell Engineering at Johns Hopkins.
The discovery, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Researchers discover how natural drug fights inflammation
